Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- GENERICS NEWS IN BRIEF
October 12, 2009
- Teijin Pharma Pursues Synergism between Drugs and Homecare Business
October 12, 2009
- OPINION／Why Negatives Never Make a Positive
October 12, 2009
- BUSINESS NEWS IN BRIEF
October 12, 2009
- Korosho Proposes Distribution Scheme for Vaccines Made in Japan to Avoid Maldistribution
October 12, 2009
- TOPICS 2 articles
October 12, 2009
- Flu Vaccines to Be Imported from GSK, Novartis
October 12, 2009
- Japan's First DPP-4 Inhibitor Sitagliptin to Be Approved
October 12, 2009
- Gov't to Procure Flu Vaccines for 77 Million Persons
October 12, 2009
- Eisai Applies for Non-Erosive GERD in Japan as Additional Indication for Pariet
October 12, 2009
- SURVEY／20% of Respondents Reluctant to Receive New-Type Flu Vaccines
October 12, 2009
- Eisai, Abbott Japan Apply for Humira for Crohn's Disease
October 12, 2009
- SEMINAR／Patients' Awareness of RA Treatment Insufficient: Prof. Yamamoto
October 12, 2009
- Parliamentary Secretary Shinya Adachi to Evaluate Chuikyo Membership
October 12, 2009
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 12, 2009
- REGULATORY NEWS IN BRIEF
October 12, 2009
- Mediceo to Further Cut Distribution Costs
October 12, 2009
- Astellas Concentrates Drug Discovery Functions in Tsukuba
October 12, 2009
- Eisai Ties Up with DNDi for Chagas Disease
October 12, 2009
- New Antibody Drugs for Cancer Highlighted at JCA Annual Meeting
October 12, 2009
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…